B-RAF with PLX4032
From Proteopedia
(Difference between revisions)
| Line 8: | Line 8: | ||
<scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>V600E Mutation</scene> <br> | <scene name='B-RAF_with_PLX4032/Mutated_v600e/1'>V600E Mutation</scene> <br> | ||
<scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> <br> | <scene name='B-RAF_with_PLX4032/Plx4032_n/1'>PLX4032 Sulfonamide N</scene> <br> | ||
| + | <scene name='B-RAF_with_PLX4032/H-bond/1'>H-Bond Interaction Asp594 and PLX4032</scene> <br> | ||
<scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene><br> | <scene name='B-RAF_with_PLX4032/Dfg_in_conformation/1'>DFG in</scene><br> | ||
<scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene> | <scene name='B-RAF_with_PLX4032/Phe_595_dfg_out/1'>DFG out</scene> | ||
<applet load='3og7' size='700' color='white' frame='true' align='center' caption='testcaption' /> | <applet load='3og7' size='700' color='white' frame='true' align='center' caption='testcaption' /> | ||
<applet load='1uwh' size='700' color='white' frame='true' align='center' caption='testcaption' /> | <applet load='1uwh' size='700' color='white' frame='true' align='center' caption='testcaption' /> | ||
Revision as of 02:30, 29 September 2010
B-RAF with PLX4032
PLX4032 is a newly synthesized drug that is being used to treat malignant melanonma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.
|
|
